Veterinary Molecular Diagnostics Market Outlook 2031: Global Value Rising from USD 543.9 Million in 2022 to USD 1.1 Billion by 2031 Amid 7.9% CAGR Driven by Pet Ownership, Vector-Borne Diseases, and Advanced PCR Technologies

The global veterinary molecular diagnostics market is entering a high-growth decade marked by rapid technological advancements, rising pet ownership, increasing prevalence of infectious diseases, and strong investments in R&D. Valued at US$ 543.9 Mn in 2022, the industry is projected to more than double, reaching US$ 1.1 Bn by 2031, expanding at a CAGR of 7.9% between 2023 and 2031. This robust progress reflects the growing need for accurate, rapid, and advanced diagnostics across companion animals and livestock.

Discover Market Opportunities - Request Your Sample Copy Now: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=42437

Analyst Viewpoint: Technology Innovation and Rising Disease Burden Accelerate Market Expansion

Analysts emphasize that the strong market trajectory is shaped by advancements in PCR technologies, automation of cytology workflows, increased investment from diagnostic companies, and the emergence of new pathogens that require molecular-level detection. Traditional diagnostics such as ELISA, agar gel immunodiffusion, and microscopy continue to be used; however, they are often time-consuming, subjective, and limited by manual interpretation.

Manufacturers are therefore focusing heavily on innovative analyzers, improved reagent kits, and automation-driven molecular platforms that deliver consistent results while reducing human error. Many vendors are also partnering with technology companies to integrate AI-driven image analysis, expanding their diagnostic depth and speed.

Market Introduction and Technological Evolution

Veterinary molecular diagnostics employ advanced techniques such as conventional PCR, singleplex PCR, multiplex PCR, and real-time PCR to evaluate DNA, RNA, and protein markers in animals. These methods are particularly vital for the detection of vector-borne diseases, respiratory pathogens, diarrhea-causing organisms, and a range of bacterial, viral, parasitic, and fungal infections.

While molecular diagnostics have been used in human healthcare for decades, their adoption in veterinary medicine has gained traction only in recent years. The shift is primarily due to improvements in PCR accuracy, affordability of high-throughput devices, and increased awareness among veterinary practitioners.

New techniques such as Western blotting, enhanced immunoassays, proteomic technologies, and biosensor-integrated diagnostics are strengthening the industry's capability to detect emerging and difficult-to-diagnose pathogens. The integration of genomic sequencing and bioinformatics into veterinary workflows further boosts the market by enabling high-throughput data analysis and personalized disease management for animals.

Growing Pet Ownership and Rising Healthcare Spending Fuel Market Demand

One of the most influential drivers of the global veterinary molecular diagnostics market is the steady growth in pet ownership, especially in developed economies. In the United States alone, 66% of households-equivalent to 86.9 million homes-own a pet as of 2024, according to the American Pet Products Association. This massive rise in pet adoption has led to increased healthcare expenditure per animal, including preventive diagnostics and molecular tests.

Another accelerating trend is the rise in pet obesity, which acts as a precursor to several diseases. In the U.S., 59% of dogs and 61% of cats were classified as overweight or obese in 2022, according to the Association for Pet Obesity Prevention. This rising disease susceptibility strengthens the need for diagnostic precision and early detection.

Explore Strategies & Trends - Request Full Report Access - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=42437

Increasing Prevalence of Vector-Borne Diseases Boosts Testing Volumes

Vector-borne diseases-transmitted by ticks, fleas, mosquitoes, and other vectors-are increasing in incidence globally. Conditions such as Lyme disease, anaplasmosis, ehrlichiosis, and leishmaniasis have witnessed rising reports across continents. According to the World Health Organization, vector-borne diseases cause over 700,000 deaths annually and constitute more than 17% of all infectious diseases.

As new pathogens emerge or re-emerge due to climate changes and geographic shifts, veterinary clinics and diagnostic laboratories increasingly rely on high-sensitivity molecular diagnostics for accurate identification. PCR-based assays and rapid molecular kits have become essential tools for early intervention and effective disease management.

R&D Advancements and Genomic Innovations Reshape the Market Landscape

Innovation is at the core of the veterinary molecular diagnostics market. Companies are investing heavily in genomic sequencing technologies, data analytics, AI-enhanced diagnostics, and improved molecular reagents. DNA sequencing platforms have become more affordable and scalable, enabling even smaller laboratories to adopt advanced diagnostic workflows.

Researchers across India, China, and other developing nations are leveraging genomic technologies to analyze disease patterns, improve livestock productivity, and strengthen food security. These advancements are expected to significantly contribute to the global market expansion through 2031.

Kits & Reagents Segment Dominates Due to Ease of Use and Accuracy

Among all product categories, kits and reagents remain the largest and fastest-growing segment, driven by their ease of use, ready-to-deploy format, and compatibility with various PCR and molecular systems. These kits reduce workflow complexities, allowing veterinarians to test for a wide spectrum of pathogens with minimal training.

North America Leads the Global Market

North America dominated the market in 2022 due to its high pet ownership rates, advanced veterinary healthcare ecosystem, and early adoption of molecular diagnostic technologies. The region is also witnessing continuous product innovations. For instance, in July 2023, Alveo Technologies launched a partner platform to accelerate co-development of rapid diagnostics across veterinary and life sciences sectors.

Competitive Landscape: AI-Integrated Diagnostics Gain Momentum

Leading companies such as IDEXX Laboratories, Zoetis, Thermo Fisher Scientific, Neogen, bioMérieux, QIAGEN, and others are integrating AI into diagnostic platforms to deliver faster and more accurate results. Key innovations include:

IDEXX inVue Dx Cellular Analyzer (2024): the first slide-free cellular analyzer for cytology.
Zoetis Vetscan Imagyst AI Urine Sediment (2024): expands AI capabilities for in-clinic urinary diagnostics.
These advancements highlight the market's move toward automation, AI, cloud connectivity, and real-time diagnostics.

Conclusion: A Decade of High Growth and Technological Advancement

The veterinary molecular diagnostics market is poised for a strong decade, with its value projected to rise from US$ 543.9 Mn in 2022 to US$ 1.1 Bn by 2031. Driven by technological innovation, rising disease burden, and increasing animal healthcare investments, the sector will continue to transform veterinary diagnostics through automation, genomic analysis, AI integration, and high-precision PCR assays. As awareness and adoption grow worldwide, molecular diagnostics will become a core pillar of modern veterinary medicine.

Buy Full Report Now: https://www.transparencymarketresearch.com/checkout.php?rep_id=42437<ype=S

Explore Latest Research Reports by Transparency Market Research:

Microplate Reader Market: https://www.transparencymarketresearch.com/microplate-readers-market.html

Dental Bone Void Filler Market: https://www.transparencymarketresearch.com/dental-bone-void-filler-market.html

Automated External Defibrillators Market Insights : https://www.transparencymarketresearch.com/automated-external-defibrillator.html

Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.